$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of indications for Mirikizumab
2026-02-01 22:25:32
Check Details
Effectiveness of Mirikizumab in clinical treatment
2026-02-01 22:25:32
Check Details
The status of the launch of Mirikizumab
2026-02-01 22:25:32
Check Details
Possible side effects of Mirikizumab
2026-02-01 22:25:32
Check Details
Mirikizumab usage and dosage guidelines
2026-02-01 22:25:32
Check Details
The pharmacological mechanism and efficacy of Mirikizumab
2026-02-01 22:25:32
Check Details
Who is the manufacturer of Mirikizumab?
2026-02-01 22:25:32
Check Details
Latest price updates for imported Mirikizumab in 2025
2026-02-01 22:25:32
Check Details
Sparsentan/sparsentan Chinese instructions
2026-02-01 22:25:32
Check Details
Sparsentan/sparsentan binds to the target through those forces
2026-02-01 22:25:32
Check Details
Import price of sparsentan/sparsentan in 2025
2026-02-01 22:25:32
Check Details
Pharmacological properties and clinical applications of sparsentan/sparsentan
2026-02-01 22:25:32
Check Details
1
2
...
1254
1255
1256
1257
1258
1259
1260
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
3
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
4
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)